Gewählte Publikation:
Peskar, BA; Cawello, W; Rogatti, W; Rudofsky, G.
On the metabolism of prostaglandin E1 administered intravenously to human volunteers.
J Physiol Pharmacol. 1991; 42(3):327-331
PubMed
Google Scholar
- Führende Autor*innen der Med Uni Graz
-
Peskar Bernhard
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Abstract:
- We have demonstrated recently the formation of a biologically active metabolite of prostaglandin (PG) E1, 13,14-dihydro-PGE1, during intravenous infusions of PGE1 in patients with peripheral arterial occlusive disease. We have now investigated the levels of the immediate precursor of 13,14-dihydro-PGE1, the biologically inactive 15-keto-13,14-dihydro-PGE1, during intravenous administration of 20 micrograms, 40 micrograms or 80 micrograms PGE1 over a period of 60 min to human volunteers. It was found that levels of 15-keto-13,14-dihydro-PGE1, but not those of PGE1 itself, increased in a dose-dependent manner. Thus, increased formation of 13,14-dihydro-PGE1 from 15-keto-13,14-dihydro-PGE1 with increasing doses of PGE1 can be expected to occur. It remains to be investigated, to which extent formation of small amounts of 13,14-dihydro-PGE1 during intravenous infusion of PGE1 could contribute to the therapeutic effects of PGE1 in patients with peripheral arterial occlusive disease.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adult -
-
Alprostadil - blood
-
Dinoprostone - analogs and derivatives
-
Dose-Response Relationship, Drug - analogs and derivatives
-
Humans - analogs and derivatives
-
Infusions, Intravenous - analogs and derivatives
-
Male - analogs and derivatives